C O M M U N I C A T I O N S
Scheme 4. Cross-Coupling and Final Conversion to CoQ10
Applications of Ubiquinone; Lenaz, G., Ed.; Wiley: New York, 1985.
Coenzyme Q: Molecular Mechanisms in Health and Disease; Kagan, V.
E., Quinn, P. J., Eds.; CRC Press: Boca Raton, FL, 2001.
(4) Negishi, E.-i.; Liou, S.-Y.; Xu, C.; Huo, S. Org. Lett. 2002, 4, 261. Van
Liemt, W. B. S.; Steggerda, W. F.; Esmeijer, R.; Lugtenburg, J. Recl.
TraV. Chim. Pays-Bas 1994, 113, 153. Duralski, A. A.; Watts, A.
Tetrahedron Lett. 1992, 33, 4983. Yanagisawa, A.; Nomura, N.; Nobuy-
oshi, N.; Noritake, Y.; Yamamoto, H. Synthesis 1991, 12, 1130. Ru¨ttimann,
A.; Lorenz, P. HelV. Chim. Acta 1990, 73, 790. Eren, D.; Keinan, E. J.
Am. Chem. Soc. 1988, 110, 4356. Eto, H.; Eguchi, C. Chem. Lett. 1988,
1597. Mohri, M.; Kinoshita, H.; Inomata, K.; Kotake, H.; Takagaki, H.;
Yamazaki, K. Chem. Lett. 1986, 1177. Sato, K.; Miyamoto, O.; Inoue,
S.; Yamamoto, T.; Hirasawa, Y. J. Chem. Soc., Chem. Commun. 1982, 3,
153. Naruta, Y. J. Org. Chem. 1980, 45, 4097. Terao, S.; Kato, K.;
Shiraishi, M.; Morimoto, H. J. Org. Chem. 1979, 44, 868. Terao, S.; Kato,
K.; Shiraishi, M.; Morimoto, H. J. Chem. Soc., Perkin Trans. 1 1978, 10,
1101. Inoue, S.; Yamaguchi, R.; Saito, K.; Sato, K. Bull. Chem. Soc. Jpn.
1974, 47, 3098. Littaru, G. P.; Ho, L.; Folkers, K. Int. J. Vitam. Nutr.
Res. 1972, 42, 291.
(5) Lipshutz, B. H.; Kim, S.-K.; Mollard, P.; Stevens, K. L. Tetrahedron 1998,
54(7), 1241. Ru¨ttimann, A.; Lorenz, P. HelV. Chim. Acta 1990, 73, 790.
Araki, S.; Sato, T.; Miyagawa, H.; Butsugan, Y. Bull. Chem. Soc. Jpn.
1984, 57, 3523. Sato, K.; Inoue, S.; Sato, H. Bull. Chem. Soc. Jpn. 1972,
45, 3455. Shunk, C. H.; Erickson, R. E.; Wong, E. L.; Folkers, K. J. Am.
Chem. Soc. 1959, 81, 5000.
(6) Lipshutz, B. H.; Bulow, G.; Fernandez-Lazaro, F.; Kim, S.-K.; Lowe, R.;
Mollard, P.; Stevens, K. L. J. Am. Chem. Soc. 1999, 121, 11664. Lipshutz,
B. H.; Bulow, G.; Lowe, R. F.; Stevens, K. L. J. Am. Chem. Soc. 1996,
118, 5512.
In summary, a novel route to CoQ10 has been realized, which
calls for six total operations (3 f 4 f 5 f 2 f 9 f 10 f CoQ10)
to arrive at ubiquinone in 64% overall yield, which constitutes the
most efficient synthesis reported to date.4,15 Synthetic CoQ10 was
identical to authentic material in all respects.16 Particularly note-
worthy is the fact that by virtue of the synthetic sequence outlined
herein, typical impurities such as the corresponding cis-isomer and
CoQ9, oftentimes found in CoQ10 which is produced industrially
almost entirely by fermentation,17 are completely averted.
(7) Kanazawa, M.; Takahashi, T. In Biochemical and Clinical Aspects of
Coenzyme Q10; Yamamura, Y., Folkers, K., Ito, Y., Eds.; Elsevier:
Amsterdam, 1981; Vol. III, p 31. Rowland, R. L.; Latimer, P. H.; Giles,
J. A. J. Am. Chem. Soc. 1956, 78, 4680. Solanesol was provided to us by
Bommidala Brothers of Guntur (India), imported via Sarchem Labs
(Navesink, NJ).
Acknowledgment. Financial support provided by the ACS
(Cope Scholar award to B.H.L.), the NSF (CHE 97 34813), and
Boehringer-Ingelheim in the form of a graduate student fellowship
(to S.S.P.) is warmly acknowledged. We are indebted to Dr. Sam
Kumar (Sarchem Labs) for supplying solanesol, Mr. Raj Chopra
(Tishcon Corp.) for providing authentic samples of CoQ10, and Mr.
Jack Etheridge (Organic Technologies) for a generous sample of
TMS-propyne used in this work.
(8) Corey, E. J.; Ruecker, C. Tetrahedron Lett. 1982, 23, 719. TMS-propyne
was supplied to us by Organic Technologies.
(9) Other organic intermediates were provided by Sarchem Labs (NJ).
(10) Paul, E. G.; Wang, P. S.-C. J. Org. Chem. 1979, 44, 2307. Aquila, v. H.
Liebigs Ann. Chem. 1969, 721, 220.
(11) Negishi, E. Acc. Chem. Res. 1987, 20, 65. Negishi, E.; Van Horn, E. E.;
Yoshida, T. J. Am. Chem. Soc. 1985, 107, 6639. Negishi, E. Pure Appl.
Chem. 1981, 53, 2333. Van Horn, D. E.; Negishi, E. J. Am Chem. Soc.
1978, 100, 2252. Wipf, P.; Ribe, S. Org. Lett. 2001, 3, 1503.
(12) Schaus, S. E.; Brandes, B. D.; Larrow, J. F.; Tokunaga, M.; Hansen, K.
B.; Gould, A. E.; Furrow, M. E.; Jacobsen, E. N. J. Am. Chem. Soc. 2002,
124, 1307. Nonracemic material was used for convenience; it is com-
achirex.com.
Note Added in Proof: Results from a recently completed
study by the NIH on the beneficial effects of CoQ10 on those
who suffer from Parkinson’s disease have been disclosed; see
(13) The simpler, achiral Co(salen) complex works well, although the isolated
yield was 84%, the remaining mass corresponding to ubiquinol. Thus,
the limited lifetime of this catalyst relative to the Jacobsen analogue
Supporting Information Available: Experimental procedures and
spectroscopic data for all intermediates (PDF). This material is available
appears to be responsible for the incomplete oxidation of 10 to CoQ10
.
Bazendale, I. R.; Lee, A.-L.; Ley, S. V. Synlett 2001, 9, 1482. Kraus, G.
A.; Choudhury, P. K. Tetrahedron Lett. 2001, 42, 6649. Van Dort, H.
M.; Geursen, H. J. Recl. TraV. Chim. Pays-Bas 1967, 86, 520.
References
(14) Dockal, E. R.; Cass, Q. B.; Brocksom, T. J.; Brocksom, U.; Correa, A.
(1) Garrett, R. H.; Grisham, C. M. Biochemistry; Saunders College Publish-
ing: Orlando, 1999. Stryer, L. Biochemistry; W. H. Freeman and
Company: New York, 1995. Nelson, D. L.; Cox, M. M. Lehninger
Principles of Biochemistry; Worth Publishers: New York, 2000.
G. Synth. Commun. 1985, 15, 1033.
(15) A patent application has been filed by the UC Office of Technology
Transfer.
(16) Provided to us by Tiscon Corp. (New York).
(2) Bliznakov, E. G.; Hunt, G. L. The Miracle Nutrient Coenzyme Q10
;
Elsevier/North-Holland Biomedical Press: New York, 1986.
(17) Sasikala, C.; Ramana, C. V. AdV. Appl. Microbiol. 1995, 41, 173.
(3) Sinatra, S. T. The Coenzyme Q10 Phenomenon; Keats Publishing: New
Canaan, 1998. Coenzyme Q: Biochemistry, Bioenergetics, and Clinical
JA021015V
9
J. AM. CHEM. SOC. VOL. 124, NO. 48, 2002 14283